We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$2.27B
AUM Growth
+$65.9M
Cap. Flow
+$29.1M
Cap. Flow %
1.28%
Top 10 Hldgs %
26.99%
Holding
261
New
19
Increased
108
Reduced
88
Closed
4

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$16.1M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.61M
3
PM icon
Philip Morris
PM
+$5.13M
4
ST icon
Sensata Technologies
ST
+$5.01M
5
MA icon
Mastercard
MA
+$4.63M

Top Sells

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$15.9M
2
TTD icon
Trade Desk
TTD
+$5.56M
3
WDAY icon
Workday
WDAY
+$5.36M
4
WFC icon
Wells Fargo
WFC
+$4.26M
5
SBUX icon
Starbucks
SBUX
+$4.16M

Sector Composition

Rank Sector Weight
1 Financials 17.96%
2 Technology 16.75%
3 Healthcare 10.45%
4 Consumer Discretionary 8.42%
5 Consumer Staples 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSTX
251
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$53K ﹤0.01%
3,829
– –
NOK icon
252
Nokia
NOK
$46.9B
$51K ﹤0.01%
10,000
-4,000
-29% -$20.6K
DAKT icon
253
Daktronics
DAKT
$946M
$41K ﹤0.01%
40,989
– –
PTN
254
Palatin Technologies
PTN
$14.4M
$23K ﹤0.01%
20
– –
CATX icon
255
Perspective Therapeutics
CATX
$327M
$18K ﹤0.01%
5,482
– –
CFRX
256
DELISTED
ContraFect Corporation
CFRX
$5K ﹤0.01%
17
– –
BMY icon
257
Bristol-Myers Squibb
BMY
$129B
– –
-6,075
Closed -$276K
SNY icon
258
Sanofi
SNY
$107B
– –
-5,813
Closed -$252K
VRDN icon
259
Viridian Therapeutics
VRDN
$2.2B
– –
-800
Closed -$25K
WDAY icon
260
Workday
WDAY
$41.5B
– –
-26,046
Closed -$5.36M
7 8 9 10
11

Similar funds

AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
GFM
GF Fund Management Guangzhou, China $5.98B AUM 80.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Crestwood Advisors Group's Q3 2019 Portfolio in Review

As of Q3 2019, Crestwood Advisors Group held 261 positions worth $2.27B, up 3% from $2.21B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Crestwood Advisors Group's Q3 2019 filing shows 19 new, 108 increased, 88 reduced and 4 closed positions. Its largest new stake was Zoetis: 133,326 shares worth $16.6M. The largest sale was Union Pacific, an estimated $15.9M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Crestwood Advisors Group's largest Q3 2019 buy was Zoetis: 133,326 shares worth $16.6M.
  • Crestwood Advisors Group added most to iShares Core S&P 500 ETF in Q3 2019, an estimated $5.61M increase.
  • Crestwood Advisors Group's biggest Q3 2019 reduction was Union Pacific, cutting an estimated $15.9M.
  • Crestwood Advisors Group fully exited Workday in Q3 2019, selling an estimated $5.36M.
  • Crestwood Advisors Group's ten largest holdings make up 27% of its $2.27B portfolio in Q3 2019.
  • Crestwood Advisors Group opened 19 new positions and closed 4 in Q3 2019.
  • Crestwood Advisors Group's portfolio value rose 3% quarter-over-quarter to $2.27B.

Based on Crestwood Advisors Group's 13F filing for Q3 2019, filed 13 Nov 2019.